Zofran (ondansetron) is an anti-nausea drug developed by GlaxoSmithKline to treat nausea and vomiting in patients undergoing chemotherapy and surgery. It blocks the actions of chemicals in the body that can trigger nausea and vomiting.
Zofran is considered a Category B drug for use in pregnant women by the United States Food and Drug Administration (FDA), which indicates there is little controlled data on the effect of the drug on an unborn child. The FDA never approved Zofran to treat morning sickness and nausea while pregnant, but the drug has been used “off-label” by pregnant women since it was introduced.
Recent studies have shown that Zofran significantly increases the risk of certain types of birth defects when taken during pregnancy. Zofran has been shown to increase the risk of these birth defects:
If you or a loved one used Zofran for nausea or morning sickness while pregnant and had a baby born with heart defects, cleft palate, or cleft lip you may be entitled to compensation. If you need help figuring out your rights, contact one of the injury attorneys at Goldblatt + Singer. We have collected millions of dollars for victims of dangerous drugs.
📚 Get AI-powered insights from this content:
Jeff Singer, Managing Partner at Goldblatt + Singer for over a decade, is a seasoned personal injury attorney known for his compassionate yet tough advocacy. He has resolved hundreds of cases and recovered millions for clients. Recognized as a Missouri Super Lawyer and Top 100 National Trial Lawyer, Jeff also serves on the Missouri Bar’s Chief Disciplinary Committee and the Board of Governors for the Missouri Association of Trial Attorneys.
This page has been created, edited, and reviewed by a team of legal writers following our thorough editorial guidelines. It was approved by our Founding Partner, Jeffrey Singer, who has over 30 years of experience as a personal injury attorney.